EXPN:LSEExperian PLC Analysis
Data as of 2026-06-21 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
Experian plc is trading at £2,542, just below its 20‑day SMA of £2,574 and facing bearish MACD momentum, while the RSI sits at a neutral 45, suggesting limited upside in the near term. The stock’s price is above the DCF‑derived fair value of £1,664, indicating a potential overvaluation on a cash‑flow basis, yet its forward PE of 14.5 and current PE of 20.5 are well below the industry average of 31.4, pointing to relative cheapness. A strong dividend yield of 2.03% with a payout ratio under 40% and robust free cash flow support dividend sustainability. Fundamentals remain solid – revenue growth of 12.3%, ROE of 28%, and operating margins above 25% – and analysts collectively rate the stock a "strong buy" with a median target near £4,014. Material news highlights that the AI boom could reinforce Experian’s market position, even as shares have slipped to decade‑low levels, adding a catalyst for a rebound. Volatility is elevated at 32% over 30 days, but beta is low, reflecting limited market‑wide sensitivity. With support around £2,203 and resistance near £2,703, the technical picture is mixed, but the company’s global footprint and data‑driven services mitigate sector and geographic risks.
Market Outlook
Short Term
< 1 yearKey Factors
- Bearish MACD and price below short‑term SMA
- High short‑term volatility and proximity to support level
- Attractive dividend yield providing downside cushion
Medium Term
1–3 yearsKey Factors
- Strong revenue growth and high ROE
- Valuation discounts to industry PE multiples
- Analyst consensus of strong‑buy and favorable earnings outlook
Long Term
> 3 yearsKey Factors
- AI‑driven data analytics positioning as a growth catalyst
- Sustainable dividend policy with solid free cash flow
- Diversified global exposure reducing concentration risk
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.